Forwarded from 🛢WTI, Brent Crude Oil, NGAS Trading 📊
🛢️ Oil Jumped $10 In 50 Minutes After Reports Iran Is Mining Hormuz
💥Today’s oil volatility was not random
It was the market repricing the probability of a prolonged shipping blockade.
1️⃣ Oil Sold Off
Earlier in the day crude prices dropped sharply.
2 drivers triggered the selloff:
• Trump said the Iran war could end “very soon”
• Talk of IEA/G7 emergency oil stock releases
That narrative suggested a quick reopening of the Strait of Hormuz.
Funds took profits.
#Brent and #WTI briefly fell back into the high-$70s / low-$80s range.
2️⃣ Mines In Hormuz
Then the story changed.
US intelligence reports indicated Iran may be deploying naval mines in the Strait of #Hormuz.
Markets reacted immediately.
Oil jumped more than $10 per barrel in about 50 minutes as traders realized:
➡️ This is no longer just political tension
➡️ It could become a physical shipping blockade
⚙️ Why Mines Change Everything
Missiles or drones create risk.
Mines create closure.
In a narrow chokepoint like Hormuz they:
• Persist in the water
• Require specialized clearing operations
• Increase insurance costs dramatically
• Keep tankers away even after the conflict cools
Clearing a mined strait can take weeks or even months.
📊 Where Oil Closed
Despite the intraday surge, official settlements were lower:
• WTI $83.7/bbl
• Brent $92.1/bbl
Still 30% higher than a month ago.
Today’s oil round-trip tells the story perfectly.
The selloff priced a quick ceasefire.
The $10 spike priced the possibility that the world’s most important oil artery could be mined.
And until tanker traffic normalizes.
The market will keep trading every headline out of Hormuz.
#oott
💥Today’s oil volatility was not random
It was the market repricing the probability of a prolonged shipping blockade.
1️⃣ Oil Sold Off
Earlier in the day crude prices dropped sharply.
2 drivers triggered the selloff:
• Trump said the Iran war could end “very soon”
• Talk of IEA/G7 emergency oil stock releases
That narrative suggested a quick reopening of the Strait of Hormuz.
Funds took profits.
#Brent and #WTI briefly fell back into the high-$70s / low-$80s range.
2️⃣ Mines In Hormuz
Then the story changed.
US intelligence reports indicated Iran may be deploying naval mines in the Strait of #Hormuz.
Markets reacted immediately.
Oil jumped more than $10 per barrel in about 50 minutes as traders realized:
➡️ This is no longer just political tension
➡️ It could become a physical shipping blockade
⚙️ Why Mines Change Everything
Missiles or drones create risk.
Mines create closure.
In a narrow chokepoint like Hormuz they:
• Persist in the water
• Require specialized clearing operations
• Increase insurance costs dramatically
• Keep tankers away even after the conflict cools
Clearing a mined strait can take weeks or even months.
📊 Where Oil Closed
Despite the intraday surge, official settlements were lower:
• WTI $83.7/bbl
• Brent $92.1/bbl
Still 30% higher than a month ago.
Today’s oil round-trip tells the story perfectly.
The selloff priced a quick ceasefire.
The $10 spike priced the possibility that the world’s most important oil artery could be mined.
And until tanker traffic normalizes.
The market will keep trading every headline out of Hormuz.
#oott
HOT Biotech Stocks right now 🔥
$EDSA (Edesa Biotech):
Develops therapies for inflammatory and immune-related diseases, like dermatitis and respiratory conditions.
$IOVA (Iovance Biotherapeutics):
Pioneers TIL cell therapies using patients’ own immune cells to fight solid tumors, with an approved treatment for melanoma.
$SGMO (Sangamo Therapeutics):
Advances gene and genomic medicine therapies, including gene editing and therapies for genetic/neurological diseases like Fabry and hemophilia.
$EDSA (Edesa Biotech):
Develops therapies for inflammatory and immune-related diseases, like dermatitis and respiratory conditions.
$IOVA (Iovance Biotherapeutics):
Pioneers TIL cell therapies using patients’ own immune cells to fight solid tumors, with an approved treatment for melanoma.
$SGMO (Sangamo Therapeutics):
Advances gene and genomic medicine therapies, including gene editing and therapies for genetic/neurological diseases like Fabry and hemophilia.